Maven Securities LTD C4 Therapeutics, Inc. Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.06 - $26.46 $91,150 - $476,650	-18,014 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $360,099 - $598,605	18,014 New	18,014 $437,000
Q3 2021 Nov 15, 2021	SELL	$35.91 - $50.5 $8.33 Million - $11.7 Million	-231,925 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $4.77 Million - $6.62 Million	156,925 Added 209.23%	231,925 $8.96 Million
Q1 2021 May 17, 2021	SELL	$31.96 - $46.5 $853,076 - $1.24 Million	-26,692 Reduced 26.25%	75,000 $2.74 Million
Q4 2020 Feb 12, 2021	BUY	$22.8 - $37.05 $2.32 Million - $3.77 Million	101,692 New	101,692 $3.66 Million

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $214M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.